TBG Operations, The Anti-Agency

+150% CSO LinkedIn engagement in four months Turning a clinical-stage CSO's expertise into an investor-ready narrative

Content Production. Clinical-stage biotech, preparing a Series C raise

[ The story ]

Situation, work, outcome.

  • The situation

    The science was strong, but the only people who could describe it accurately had no time and less interest in writing publicly. Investor and BD conversations kept starting from zero instead of from a credible public narrative.

  • What we did

    Monthly structured interviews with the CSO, turned into an executive thought-leadership track for LinkedIn and investor-relevant framing — alongside technical briefs written for a BD audience that needed to understand the platform without a PhD.

  • What changed

    • +150%

      CSO LinkedIn engagement in four months

    • Standard

      Technical briefs became pre-read for every BD conversation

    • >50%

      Less “explain the science from scratch” time on first calls

Client names stay under NDA.

[ Get in touch ]

Brief us something.

Tell us what is stuck. You get a written plan before you commit to anything.